Company Filing History:
Years Active: 2002-2003
Title: Jean-François Riou: Innovator in Cancer Therapy
Introduction
Jean-François Riou is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 2 patents, Riou's work focuses on developing novel chemical compounds that have therapeutic applications in humans.
Latest Patents
Riou's latest patents include groundbreaking work on chemical derivatives and their application as antitelomerase agents. This invention relates to cancer therapy and introduces a novel anticancer agent with a specific mechanism of action. Additionally, he has developed compositions that contain at least one farnesyl transferase inhibitor and at least one topoisomerase inhibitor. Another significant patent involves combinations of farnesyl transferase inhibitors and taxoids, showcasing his innovative approach to cancer treatment.
Career Highlights
Throughout his career, Jean-François Riou has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma Rorer S.A. and Aventis Pharma S.A. His experience in these organizations has allowed him to contribute to the advancement of cancer therapies and the development of effective treatments.
Collaborations
Riou has collaborated with esteemed colleagues such as Patrick Mailliet and Patricia Vrignaud. These partnerships have further enriched his research and innovation in the field of cancer therapy.
Conclusion
Jean-François Riou's contributions to cancer therapy through his patents and collaborations highlight his role as a significant innovator in the pharmaceutical industry. His work continues to pave the way for advancements in cancer treatment and therapeutic applications.